Initial studies of RotaTeq comprised of studies of the parent strain, various combinations of serotypes and the concept of creating reassortant vaccines. Following positive results from initial ...

Please provide your email address to receive an email when new articles are posted on . The Children’s Hospital of Philadelphia and The Wistar Institute recently celebrated the 10th anniversary of the ...

Eight children who received Merck & Co's RotaTeq vaccine developed a rare blood-vessel disorder that can lead to aneurysms and heart attacks, and the company is adding a warning to its label. Eight ...

When supplies are strained, what gives? For Merck & Co., in the midst of global production constraints, it's phasing out shipments of cut-rate RotaTeq doses to Africa while pushing its China launch ...

Significant Step in Merck's Efforts to Expand Global Access to Rotavirus Vaccine WHITEHOUSE STATION, N.J., Oct. 10, 2008 - ROTATEQ® (rotavirus vaccine, live, oral, pentavalent), the pentavalent ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — The Children’s Hospital of Philadelphia and The Wistar Institute recently celebrated the 10th ...

Merck & Co’s Rotateq vaccine against rotavirus infection won an important endorsement yesterday after a US Centers for Disease Control advisory committee voted to include it in routine infant ...

Bear Stearns maintained a "peer perform" rating on Merck after the company said it received regulatory approval for RotaTeq, a treatment for an infantile digestive disease. Shares of Merck rose late ...

Rotarix on par with Rotateq for rotavirus gastroenteritis The monovalent rotavirus vaccine is more than 90% effective at preventing rotavirus, putting the vaccine's efficacy on par with the ...

Appeals court finds physician purchasing groups had authority to negotiate arbitration clauses Plaintiffs accused Merck of threatening higher prices on other products to keep rotavirus vaccine ...

The three-dose oral pentavalent reassortant RV vaccine has been shown to be highly efficacious and well tolerated in one large clinical trial and subsequent postmarketing surveillance. It is currently ...